| Year |
Citation |
Score |
| 2022 |
Cichocki F, Bjordahl R, Goodridge JP, Mahmood S, Gaidarova S, Abujarour R, Davis ZB, Merino A, Tuininga K, Wang H, Kumar A, Groff B, Witty A, Bonello G, Huffman J, et al. Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma. Nature Communications. 13: 7341. PMID 36446823 DOI: 10.1038/s41467-022-35127-2 |
0.3 |
|
| 2022 |
D'Souza SS, Kumar A, Maufort J, Weinfurter JT, Raymond M, Strelchenko N, Perrin E, Coonen J, Mejia A, Simmons H, Torbett BE, Reynolds M, Thomson JA, Slukvin I. Assessment of Safety and Immunogenicity of MHC homozygous iPSC-derived CD34+ Hematopoietic Progenitors in a NHP Model. Blood Advances. PMID 35404997 DOI: 10.1182/bloodadvances.2022006984 |
0.362 |
|
| 2022 |
D'Souza SS, Kumar A, Weinfurter J, Park MA, Maufort J, Tao L, Kang H, Dettle ST, Golos T, Thomson JA, Reynolds MR, Slukvin I. Generation of SIV-resistant T cells and macrophages from nonhuman primate induced pluripotent stem cells with edited CCR5 locus. Stem Cell Reports. PMID 35364011 DOI: 10.1016/j.stemcr.2022.03.003 |
0.304 |
|
| 2021 |
D'souza SS, Kumar A, Maufort JP, Strelchenko N, Raymond M, Weinfurter J, Coonen J, Reynolds M, Thomson JA, Slukvin II. Infusion of iPSC-Derived CD34 + Hematopoietic Progenitors Following Myeloablative HSC Transplantation and Assessment of Their Immunogenicity in MHC-Defined Nonhuman Primate Model Blood. 138: 2763-2763. DOI: 10.1182/blood-2021-149003 |
0.318 |
|
| 2020 |
Kumar A, D'Souza SS, Uenishi G, Park MA, Lee JH, Slukvin II. Generation of T cells from Human and Nonhuman Primate Pluripotent Stem Cells. Bio-Protocol. 10: e3675. PMID 33659345 DOI: 10.21769/BioProtoc.3675 |
0.374 |
|
| 2019 |
Kumar A, D'Souza SS, Thakur AS. Understanding the Journey of Human Hematopoietic Stem Cell Development. Stem Cells International. 2019: 2141475. PMID 31198425 DOI: 10.1155/2019/2141475 |
0.498 |
|
| 2018 |
Kumar A, Lee JH, Suknuntha K, D'Souza SS, Thakur AS, Slukvin II. NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 30578305 DOI: 10.4049/Jimmunol.1801027 |
0.445 |
|
| 2018 |
Slukvin II, Kumar A. The mesenchymoangioblast, mesodermal precursor for mesenchymal and endothelial cells. Cellular and Molecular Life Sciences : Cmls. PMID 29992471 DOI: 10.1007/S00018-018-2871-3 |
0.505 |
|
| 2018 |
Park MA, Kumar A, Jung HS, Uenishi G, Moskvin OV, Thomson JA, Slukvin II. Activation of the Arterial Program Drives Development of Definitive Hemogenic Endothelium with Lymphoid Potential. Cell Reports. 23: 2467-2481. PMID 29791856 DOI: 10.1016/J.Celrep.2018.04.092 |
0.433 |
|
| 2018 |
Uenishi GI, Jung HS, Kumar A, Park MA, Hadland BK, McLeod E, Raymond M, Moskvin O, Zimmerman CE, Theisen DJ, Swanson S, J Tamplin O, Zon LI, Thomson JA, Bernstein ID, et al. NOTCH signaling specifies arterial-type definitive hemogenic endothelium from human pluripotent stem cells. Nature Communications. 9: 1828. PMID 29739946 DOI: 10.1038/S41467-018-04134-7 |
0.465 |
|
| 2018 |
D'Souza SS, Kumar A, Slukvin II. Functional Heterogeneity of Endothelial Cells Derived from Human Pluripotent Stem Cells. Stem Cells and Development. PMID 29583085 DOI: 10.1089/Scd.2017.0238 |
0.46 |
|
| 2018 |
Suknuntha K, Tao L, Brok-Volchanskaya V, D'Souza SS, Kumar A, Slukvin I. Optimization of Synthetic mRNA for Highly Efficient Translation and its Application in the Generation of Endothelial and Hematopoietic Cells from Human and Primate Pluripotent Stem Cells. Stem Cell Reviews. PMID 29520567 DOI: 10.1007/S12015-018-9805-1 |
0.457 |
|
| 2017 |
Kumar A, D'Souza SS, Moskvin OV, Toh H, Wang B, Zhang J, Swanson S, Guo LW, Thomson JA, Slukvin II. Specification and Diversification of Pericytes and Smooth Muscle Cells from Mesenchymoangioblasts. Cell Reports. 19: 1902-1916. PMID 28564607 DOI: 10.1016/J.Celrep.2017.05.019 |
0.5 |
|
| 2016 |
Jung HS, Uenishi G, Kumar A, Park MA, Raymond M, Fink D, McLeod E, Slukvin I. A human VE-cadherin-tdTomato and CD43-green fluorescent protein dual reporter cell line for study endothelial to hematopoietic transition. Stem Cell Research. 17: 401-405. PMID 27879215 DOI: 10.1016/J.Scr.2016.09.004 |
0.433 |
|
| 2016 |
D'Souza SS, Maufort J, Kumar A, Zhang J, Smuga-Otto K, Thomson JA, Slukvin II. GSK3β Inhibition Promotes Efficient Myeloid and Lymphoid Hematopoiesis from Non-human Primate-Induced Pluripotent Stem Cells. Stem Cell Reports. PMID 26805448 DOI: 10.1016/J.Stemcr.2015.12.010 |
0.455 |
|
| 2015 |
D'Souza S, Maufort J, Kumar A, Thomson J, Slukvin I. Efficient Induction of Myleoid and Lymphoid Hematopoiesis from Nonhuman Primate Pluripotent Stem Cells Using GSK3b Inhibitor Blood. 126: 2363-2363. DOI: 10.1182/Blood.V126.23.2363.2363 |
0.451 |
|
| 2014 |
Uenishi G, Theisen D, Lee JH, Kumar A, Raymond M, Vodyanik M, Swanson S, Stewart R, Thomson J, Slukvin I. Tenascin C promotes hematoendothelial development and T lymphoid commitment from human pluripotent stem cells in chemically defined conditions. Stem Cell Reports. 3: 1073-84. PMID 25448067 DOI: 10.1016/J.Stemcr.2014.09.014 |
0.499 |
|
| 2014 |
Elcheva I, Brok-Volchanskaya V, Kumar A, Liu P, Lee JH, Tong L, Vodyanik M, Swanson S, Stewart R, Kyba M, Yakubov E, Cooke J, Thomson JA, Slukvin I. Direct induction of haematoendothelial programs in human pluripotent stem cells by transcriptional regulators. Nature Communications. 5: 4372. PMID 25019369 DOI: 10.1038/Ncomms5372 |
0.487 |
|
| 2014 |
Elcheva I, Brok-Volchanskaya V, Kumar A, Vodyanik M, Swanson S, Stewart R, Kyba M, Yakubov E, Cooke J, Thomson J, Slukvin I. Identification of two groups of transcriptional regulators directing blood formation from human pluripotent stem cells through distinct types of hemogenic endothelium Experimental Hematology. 42: S60. DOI: 10.1016/J.Exphem.2014.07.228 |
0.449 |
|
| 2013 |
Kumar A, Torii T, Ishino Y, Muraoka D, Yoshimura T, Togayachi A, Narimatsu H, Ikenaka K, Hitoshi S. The Lewis X-related α1,3-fucosyltransferase, Fut10, is required for the maintenance of stem cell populations. The Journal of Biological Chemistry. 288: 28859-68. PMID 23986452 DOI: 10.1074/jbc.M113.469403 |
0.335 |
|
| 2012 |
Choi KD, Vodyanik MA, Togarrati PP, Suknuntha K, Kumar A, Samarjeet F, Probasco MD, Tian S, Stewart R, Thomson JA, Slukvin II. Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures. Cell Reports. 2: 553-67. PMID 22981233 DOI: 10.1016/J.Celrep.2012.08.002 |
0.517 |
|
| 2012 |
Nagaraj SRM, Sheela ML, Yashaswini B, Kumar A, Salimath BP. MTA1 induced angiogenesis, migration and tumor growth is inhibited by Glycyrrhiza glabra Iosr Journal of Pharmacy. 2: 34-43. DOI: 10.9790/3013-24203443 |
0.317 |
|
| 2011 |
Hitoshi S, Ishino Y, Kumar A, Jasmine S, Tanaka KF, Kondo T, Kato S, Hosoya T, Hotta Y, Ikenaka K. Mammalian Gcm genes induce Hes5 expression by active DNA demethylation and induce neural stem cells. Nature Neuroscience. 14: 957-64. PMID 21765423 DOI: 10.1038/nn.2875 |
0.367 |
|
| 2011 |
Kumar A, Salimath BP, Schieker M, Stark GB, Finkenzeller G. Inhibition of metastasis‐associated gene 1 expression affects proliferation and osteogenic differentiation of immortalized human mesenchymal stem cells Cell Proliferation. 44: 128-138. PMID 21401754 DOI: 10.1111/J.1365-2184.2010.00735.X |
0.415 |
|
| 2010 |
Kumar A, Salimath BP, Stark GB, Finkenzeller G. Platelet-derived growth factor receptor signaling is not involved in osteogenic differentiation of human mesenchymal stem cells. Tissue Engineering. Part A. 16: 983-93. PMID 19839721 DOI: 10.1089/Ten.Tea.2009.0230 |
0.433 |
|
| 2009 |
Kumar A, D'Souza SS, Nagaraj SR, Gaonkar SL, Salimath BP, Rai KM. Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1alpha in Ehrlich ascites tumor cells. Cancer Chemotherapy and Pharmacology. 64: 1221-33. PMID 19370348 DOI: 10.1007/S00280-009-0992-Y |
0.351 |
|
| 2009 |
Kumar A, D'Souza SS, Tickoo S, Salimath BP, Singh HB. Antiangiogenic and proapoptotic activities of allyl isothiocyanate inhibit ascites tumor growth in vivo. Integrative Cancer Therapies. 8: 75-87. PMID 19223371 DOI: 10.1177/1534735408330716 |
0.36 |
|
| 2008 |
Kumar A, D'Souza SS, Gaonkar SL, Rai KM, Salimath BP. Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by a new series of substituted-1,3,4-oxadiazole derivatives. Investigational New Drugs. 26: 425-35. PMID 18227972 DOI: 10.1007/S10637-008-9116-5 |
0.329 |
|
| Show low-probability matches. |